Good Life Advisors LLC Sells 361 Shares of The Procter & Gamble Company (NYSE:PG)

Good Life Advisors LLC cut its holdings in shares of The Procter & Gamble Company (NYSE:PG – Get Rating) by 2.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,015 shares of the company’s stock after selling 361 shares during the period. Good Life Advisors LLC’s holdings in Procter & Gamble were worth $2,124,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the stock. Capital Investment Advisory Services LLC increased its holdings in Procter & Gamble by 4.9% in the fourth quarter. Capital Investment Advisory Services LLC now owns 36,681 shares of the company’s stock valued at $5,559,000 after purchasing an additional 1,711 shares during the period. Deuterium Capital Management LLC bought a new position in shares of Procter & Gamble during the 4th quarter worth about $675,000. CX Institutional boosted its position in shares of Procter & Gamble by 4.1% during the 4th quarter. CX Institutional now owns 33,743 shares of the company’s stock worth $5,114,000 after purchasing an additional 1,320 shares in the last quarter. Oak Harbor Wealth Partners LLC boosted its position in shares of Procter & Gamble by 11.1% during the 4th quarter. Oak Harbor Wealth Partners LLC now owns 30,891 shares of the company’s stock worth $4,682,000 after purchasing an additional 3,089 shares in the last quarter. Finally, Blue Chip Partners LLC increased its stake in Procter & Gamble by 1.9% in the 4th quarter. Blue Chip Partners LLC now owns 21,503 shares of the company’s stock valued at $3,259,000 after buying an additional 409 shares during the last quarter. 62.13% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

NYSE PG traded down $0.33 on Friday, reaching $145.06. The company had a trading volume of 2,277,418 shares, compared to its average volume of 6,383,554. The Procter & Gamble Company has a 12 month low of $122.18 and a 12 month high of $158.11. The stock has a market capitalization of $341.90 billion, a PE ratio of 25.31, a price-to-earnings-growth ratio of 4.07 and a beta of 0.41. The firm’s 50 day moving average price is $151.37 and its 200 day moving average price is $147.02. The company has a quick ratio of 0.39, a current ratio of 0.59 and a debt-to-equity ratio of 0.51.

Procter & Gamble (NYSE:PG – Get Rating) last released its quarterly earnings results on Friday, April 21st. The company reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.32 by $0.05. Procter & Gamble had a net margin of 17.69% and a return on equity of 32.18%. The firm had revenue of $20.07 billion during the quarter, compared to analysts’ expectations of $19.32 billion. During the same period in the previous year, the company earned $1.33 EPS. The firm’s revenue for the quarter was up 3.5% compared to the same quarter last year. As a group, equities analysts predict that The Procter & Gamble Company will post 5.86 earnings per share for the current year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, May 15th. Investors of record on Friday, April 21st were paid a dividend of $0.9407 per share. This represents a $3.76 annualized dividend and a dividend yield of 2.59%. The ex-dividend date of this dividend was Thursday, April 20th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.91. Procter & Gamble’s payout ratio is 65.51%.

Insider Buying and Selling

In other news, insider Susan Street Whaley sold 709 shares of the company’s stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $137.34, for a total value of $97,374.06. Following the sale, the insider now directly owns 10,198 shares of the company’s stock, valued at approximately $1,400,593.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Procter & Gamble news, CFO Andre Schulten sold 1,311 shares of the company’s stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $137.34, for a total transaction of $180,052.74. Following the completion of the transaction, the chief financial officer now directly owns 35,142 shares in the company, valued at $4,826,402.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Susan Street Whaley sold 709 shares of the stock in a transaction dated Wednesday, March 1st. The shares were sold at an average price of $137.34, for a total transaction of $97,374.06. Following the completion of the sale, the insider now owns 10,198 shares of the company’s stock, valued at $1,400,593.32. The disclosure for this sale can be found here. Insiders sold a total of 99,424 shares of company stock worth $15,416,750 in the last 90 days. 0.26% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

PG has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Procter & Gamble from $160.00 to $170.00 and gave the company a “buy” rating in a research note on Monday, April 24th. Citigroup assumed coverage on shares of Procter & Gamble in a report on Thursday, February 16th. They set a “buy” rating and a $160.00 price objective for the company. UBS Group boosted their price target on shares of Procter & Gamble from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Monday, April 24th. StockNews.com assumed coverage on shares of Procter & Gamble in a research note on Thursday, May 18th. They issued a “buy” rating for the company. Finally, Royal Bank of Canada boosted their price objective on shares of Procter & Gamble from $160.00 to $165.00 and gave the company a “sector perform” rating in a research report on Monday, April 24th. Five research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $161.50.

About Procter & Gamble

(Get Rating)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.